Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Benefit-Risk Analysis for Decision-Making: An Approach.
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
Placental Stromal Cell Therapy for Experimental Autoimmune Encephalomyelitis: The Role of Route of Cell Delivery.
Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis.
Erythropoietin reduces white matter damage in two-day-old rats exposed to hypoxic/ischemia injury.
Enhancing Approaches to the Identification and Management of Pseudobulbar Affect.
6-Month Effects of Fingolimod on Indexes of Cardiovascular Autonomic Control in Multiple Sclerosis.
Differential Item Function Analysis of a Scale Measuring Worry About Affording Healthcare in Multiple Sclerosis.
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation.
Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats.
Longitudinal Patch-Based Segmentation of Multiple Sclerosis White Matter Lesions.
Pediatric optic neuritis.
Insights into the role of iron in immature rat model of hypoxic-ischemic brain injury.
Mexican Biosimilar Filgrastim for Autologous Hematopoietic Stem Cell Mobilization and Transplantation.
Utilization of PET imaging in differential diagnostics between a tumefactive multiple sclerosis lesion and low-grade glioma.
Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder.
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
Acute Hemorrhagic Leukoencephalitis in Children: A Case Report.
Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.
Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome.
A more in-depth interpretation of MMPI-2 in MS patients by using Harris and Lingoes subscales.
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Patterns of white matter damage are non-random and associated with cognitive function in secondary progressive multiple sclerosis.
Effectiveness and safety of natalizumab in real-world clinical practice: Review of observational studies.
Pages
« first
‹ previous
…
778
779
780
781
782
783
784
785
786
…
next ›
last »